TNDM FRAUD ALERT: Jakubowitz Law is Investigating Tandem Diabetes Care, Inc. in Connection with Potential Violations of Federal Securities Laws

NEW YORK, July 14, 2023 /PRNewswire/ -- Jakubowitz Law announces that an investigation into potential securities fraud allegations has commenced on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM)

To be contacted by a member of our team, fill out the form:

https://claimyourloss.com/securities/tandem-class-action-loss-submission-form/?id=42098&from=4

Further details on the investigation: The investigation focuses on whether Tandem issued false and/or misleading statements and/or failed to disclose information pertinent to investors. After the market closed on November 2, 2022, Tandem released its third quarter 2022 results. The Company held a conference call on the same day to discuss its third quarter 2022 financial and operating results. Tandem substantially lowered its guidance for the year during the call. In response to the earnings news, market analysts downgraded Tandem and its stock price fell $14.57 per share, from $51.34 per share on November 2, 2022 to close at $36.77 per share on November 3, 2022.

Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (628) 895-0423
F: (212) 537-5887

SOURCE Jakubowitz Law

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED